Amivantamab with chemotherapy - Non-small cell lung cancer with EGFR exon 20 insertions

被引：0
|
作者：
Drappier, Noemie [1 ]
Pierret, Thomas [2 ]
机构：
[1] Univ Montpellier, Fac Med, F-34090 Montpellier, France
[2] Hosp Civils Lyon, Hop Louis Pradel, Serv Hosp Univ Pneumol, F-69500 Bron, France
来源：
BULLETIN DU CANCER | 2024年 / 111卷 / 12期
关键词：
Non-small cell lung cancer; EGFR exon 20 insertions; Amivantamab; Chemotherapy;
D O I：
10.1016/j.bulcan.2024.08.014
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1085 / 1087
页数：3
相关论文
共 50 条
  • [11] Efficacy of Mobocertinib and Amivantamab in Patients With Advanced Non-Small Cell Lung Cancer With EGFR Exon 20 Insertions Previously Treated With Platinum-Based Chemotherapy: An Indirect Treatment Comparison
    Ou, Sai -Hong Ignatius
    Prawitz, Thibaud
    Lin, Huamao M.
    Hong, Jin-liern
    Tan, Min
    Proskorovsky, Irina
    Hernandez, Luis
    Jin, Shu
    Zhang, Pingkuan
    Lin, Jianchang
    Patel, Jyoti
    Nguyen, Danny
    Neal, Joel W.
    CLINICAL LUNG CANCER, 2024, 25 (03) : e145 - e152.e3
  • [12] Efficacy of various types of chemotherapy for advanced non-small cell lung cancer with EGFR exon 20 in-frame insertions.
    Tang, Haibo
    Li, Xiaoning
    Cai, Jianhong
    Wu, Xiaomin
    Zheng, Yating
    Huang, Mengli
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [13] The state of the art of EGFR exon 20 insertions in non-small cell lung cancer: Diagnosis and future perspectives
    Dorta-Suarez, Miriam
    de Miguel, Maria
    Amor-Carron, Oscar
    Calderon, Jose Miguel
    Gonzalez-Ortega, Mcarmen
    Rodriguez-Abreu, Delvys
    CANCER TREATMENT REVIEWS, 2024, 124
  • [14] Targeting EGFR Exon 20 Insertions in Non-Small Cell Lung Cancer: Recent Advances and Clinical Updates
    Meador, Catherine B.
    Sequist, Lecia, V
    Piotrowska, Zofia
    CANCER DISCOVERY, 2021, 11 (09) : 2145 - 2157
  • [15] VEGFA mediates traditional EGFR-TKI resistance in non-small cell lung cancer with EGFR exon 20 insertions
    Yang, Yaning
    Liu, Chengming
    Yang, Guangjian
    Xu, Haiyan
    Lei, Siyu
    Wang, Yan
    CANCER RESEARCH, 2024, 84 (06)
  • [16] Amivantamab Plus Chemotherapy in Non-Small Cell Lung Cancer
    不详
    ONCOLOGY-NEW YORK, 2024, 38 (06):
  • [17] FDA Approval Summary: Amivantamab for the Treatment of Patients with Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
    Chon, Katie
    Larkins, Erin
    Chatterjee, Somak
    Mishra-Kalyani, Pallavi S.
    Aungst, Stephanie
    Wearne, Emily
    Subramaniam, Sriram
    Li, Yangbing
    Liu, Jiang
    Sun, Jielin
    Charlab, Rosane
    Zhao, Hong
    Saritas-Yildirim, Banu
    Bikkavilli, Rama Kamesh
    Ghosh, Soma
    Philip, Reena
    Beaver, Julia A.
    Singh, Harpreet
    CLINICAL CANCER RESEARCH, 2023, 29 (17) : 3262 - 3266
  • [18] Targeting EGFR exon 20 insertions in non-small cell lung cancer by exploiting a dependency on parallel SRC signalling
    Vyse, S.
    Chen, N.
    Oddy, J.
    Harrison, P.
    Le, A.
    Estrada-Bernal, A.
    Hermsen, M.
    Doebele, R.
    Huang, P.
    ANNALS OF ONCOLOGY, 2019, 30
  • [19] EGFR exon 20 insertion mutations in non-small cell lung cancer
    Wang, Fenfang
    Li, Chenghui
    Wu, Qihuan
    Lu, Hongyang
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (04) : 2982 - 2991
  • [20] Prognostic Value of EGFR Exon-20 Insertions in Czech Patients With Advanced Non-small Cell Lung Cancer
    Skrickova, Jana
    Pesek, Milos
    Opalka, Petr
    Koubkova, Leona
    Zemanova, Milada
    Hrnciarik, Michal
    Blazek, Jiri
    Svaton, Martin
    Krejci, Jana
    Coupkova, Helena
    Dolezal, Daniel
    Tuzova, Tana
    Holubec, Lubos
    Mahadevia, Parthiv
    Sandstrom, Kristina
    Kunovszki, Peter
    Barinova, Magda
    Hurdalkova, Karolina
    Fischer, Ondrej
    Cernovska, Marketa
    Bratova, Monika
    ANTICANCER RESEARCH, 2021, 41 (11) : 5625 - 5634
12345